$IMAB 3rd phase April:

https://www.globenewswire.com/news-release/2020/04/27/2022753/0/en/I-Mab-and-MorphoSys-Announce-First-Patient-Dosed-in-Phase-3-Clinical-Trial-of-TJ202-MOR202-in-r-r-Multiple-Myeloma-in-Mainland-China.html
<ticker> <number> rd phase april :